Fridays vs Piper
Piper costs $114 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Fridays
Best for: coaching bundled into the price rather than sold separately
Visit Fridays →
Piper
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Piper →If you are choosing between Fridays and Piper, the first difference is cost: Piper is $114 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Piper leads our six-part score, 7.4 to 5.5.
Fridays vs Piper price
Piper is the cheaper way in: $135 a month against $249 a month at Fridays. That is $114 less each month (46% lower), or about $1,368 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Piper ($135 a month vs $249 a month); tirzepatide is cheaper at Piper ($199 a month vs $359 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Fridays prices compounded injections and brand-name pens, while Piper prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Fridays is the only one of the two with a brand-name price.
Where each one treats patients
Fridays does not publish where it ships, and Piper lists 50 states.
Pricing
Fridays
Piper
What each price covers
Both prices cover the clinician visit and the medication itself.
Fridays' price also covers coaching, which Piper does not claim.
Piper's price also covers shipping, which Fridays does not claim.
Fridays is silent on shipping and lab work.
Piper is silent on lab work and coaching.
Fridays
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Piper
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Piper scores 7.4 and Fridays 5.5 out of 10.
Piper is stronger on user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0) and accessibility (10.0 vs 5.0).
Value, effectiveness and support are within half a point.
Fridays
5.5/10
Piper
7.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Fridays nor Piper has an FDA warning letter on record with us.
Features & Coverage
| Feature | Fridays | Piper |
|---|---|---|
| Starting Price | $249/mo | ✓$135/mo |
| Features | 2 features | ✓3 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Fridays
Fridays is a telehealth weight loss seller running compounded GLP-1 programs.
Read our full Fridays review →About Piper
Piper is a telehealth weight loss seller offering compounded GLP-1 medications at competitive prices.
Read our full Piper review →Pros & Cons
Fridays
What we like
- The monthly price includes the medication, clinician visits and coaching
- We found no FDA warning letters issued to Fridays
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $359 a month, 44% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Piper
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Piper
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Piper wins this one, 7.4 to 5.5, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $114 less each month than Fridays. Fridays fits better if coaching bundled into the price rather than sold separately is your priority.
Choose Fridays if…
You want coaching bundled into the price rather than sold separately and an opening price near $249 a month.
Choose Piper if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $135 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Fridays vs Piper: FAQ
Close alternatives to Fridays and Piper
- Fridays vs Luvo Health
- Fridays vs RxSpan MD
- Fridays vs Elevated Health
- Fridays vs Better U Care
- Piper vs Livv
- Piper vs Somi Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.